Charles Anthony Laranjeira - 22 Nov 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: Chief Technical Officer
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 22 Nov 2021
Net transactions value: +$330,750
Form type: 4
Filing time: 24 Nov 2021, 15:25:41 UTC
Previous filing: 11 Jun 2021
Next filing: 08 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Options Exercise	$330,750	+7,500	+29%	$44.10	33,602	22 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Options Exercise	$0	-7,500	-100%	$0.000000^*	0	22 Nov 2021	Common Stock	7,500	$44.10	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.
F2	The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.